The TGF-β/Smad3 signaling pathway in the liver is also a well-known key factor in advanced non-alcoholic fatty liver disease through the progression of liver fibrosis. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatotic liver disease.